MDRG, Inc.

A national CPG company wanted to assess the purchase barriers for one of their most popular sausage products. We used a System 1 methodology... and the results uncovered both expected and more nuanced findings. Read on to see what we did... https://hubs.la/Q0317ppf0

As a market research firm specializing in the healthcare, CPG, finance, and communications industries, we recognize the significant advantages of adopting a multidisciplinary approach. Successful market research goes beyond a singular focus and requires a holistic understanding of various industries. Read our blog: 5 Tips for Unlocking Hidden Insights to learn more about this can help your brand grow. https://hubs.la/Q02L1qvH0

🚀 Need to vet a new product fast? We got you covered. MDRG has embraced the future of CPG innovation with consumer-led rapid concept development! Discover how this agile approach can help your brand stay in tune with your consumers. #marketresearch #ConsumerTesting #productdevelopment https://hubs.la/Q02ngTvp0

Happy New Year from MDRG!!!

👋Team Member Feature: Liz Akins, Quantitative Research Analyst Liz just hit her year anniversary with MDRG, and we are so lucky to have her! Since joining, she has shown her versatility and intelligence by working on quantitative projects, qualitative projects, special projects, big picture projects, detailed projects, and well... ALL the projects. On top of this, she might be Taylor Swift's biggest fan (Sorry, Travis Kelce!), AND she got married this year to HER biggest fan. And we guarantee if you meet her, you'll be a Liz fan too. Get to know Liz... What's your favorite thing about your role with MDRG? 👫"My favorite thing about being at MDRG is the collaborative nature of our group. Every day, I get to brainstorm with and learn from not only my Quant teammates, but also the Qualitative and Client Insights teams. It is so great to see the way our teams show up and come together to deliver the best insights." What do you do for fun? 📖"I am a big reader, and have fun setting and working toward an annual reading goal – my 2024 goal was 52 books, which I hit in November! I also enjoy puzzles of all kinds, whether it’s a word puzzle, brain teaser, or good old fashioned jigsaw puzzle." What's your favorite beverage & why? ☕"I think I am obligated to say coffee, as I am definitely not functional without it. Besides coffee though, I really enjoy checking out the ever-growing brewery scene in Charlotte and trying new beers – nine times out of ten, my favorite will be a New England/Hazy IPA!"

Rare vs. Ultra-Rare Conditions: What's the difference? The difference matters more than you might think. While rare diseases affect fewer than 200,000 people in the U.S., ultra-rare conditions impact an even smaller population - often fewer than 20 patients per million. This distinction critically shapes FDA approval pathways: rare disease trials typically require traditional randomized controlled trials, while ultra-rare conditions often qualify for modified trial designs and accelerated approval pathways with smaller patient populations and adaptive study designs. Enter Zevra Therapeutics, revolutionizing the ultra-rare space with Miplyffa - the first FDA-approved treatment for Niemann-Pick disease type C (NPC), affecting approximately 900 people in the U.S. Through their early access program, they've treated 83 patients for up to five years, demonstrating how ultra-rare disease trials can effectively merge clinical development with early treatment access. Their strategic approach leverages regulatory flexibility, combining clinical trial awareness with commercial strategy from day one. For Zevra Therapeutics and other pharmaceutical companies in the ultra-rare diseases space, data isn't just information; it's the difference between breakthrough treatment and missed opportunity. Want to learn more on how data transforms healthcare? Let’s connect to discuss how MDRG, Inc. can help turn your data into strategic roadmaps, helping navigate everything from rare or ultra rare disease treatment commercialization to precision market entry strategies. #RareDisease #FDARegulation #PharmaBiotech #ClinicalTrials #Healthcare

From gut health drinks to AI innovations, 2024 was a transformative year for the beverage industry. See how brands like RYZE Superfoods, The Coca-Cola Company, PRIME, and Boxed Water Is Better stood out to consumers this year. Read on to see how our predictions fared: Reflecting on 2024 Beverage Trends https://hubs.la/Q030mh-L0 #marketresearch #beveragetrends #CPG 🍸

Merry Christmas and happy holidays from MDRG!

50% of Consumers Have a Tried Non-Traditional Care Provider. But Will They Go Back? Swaay.Health Marketing Community sat down with up with Sondra Brown, Founder of MDRG, at the #NESHCo24 conference to learn more about their latest healthcare consumerism report on patient expectations for retail health – the Health Experience (HX) Index Report…and to get an answer to that burning question. https://hubs.la/Q02G1cbZ0

MDRG partners with clients and agencies to conduct advertising research across the campaign development process to ✨uncover key emotions and deep attitudes✨ related to advertising. Here's a few of our methods! Check out more here: https://hubs.la/Q02MWMYG0 #messagetesting #copytesting #marketresearch